This is a first in precision medicine. This group aims to be the first to analyze brain scans together with genomic + clinical + phenotypic data to study neurodegenerative diseases at a population level then distill it down to an individual’s personal treatment plan. GIRO Health (IBM, RowAnalytics, Martinos Center & Envision Genomics) is an open initiative designed to bring together the best and the brightest to solve [PR.com]